Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Modular Medical ( (MODD) ) just unveiled an announcement.
On June 30, 2025, Modular Medical disclosed that its shares had traded below Nasdaq’s $1 minimum bid price for 30 consecutive business days, putting it out of compliance with Nasdaq’s listing standards. On December 30, 2025, Nasdaq granted the company a 180-day extension, giving it until June 29, 2026 to regain compliance by lifting its share price to at least $1 for 10 consecutive business days, with no immediate impact on the stock’s current listing or trading under the ticker “MODD.” If the company fails to meet the bid price requirement by the new deadline, its common stock faces potential delisting from the Nasdaq Capital Market, though Modular Medical could appeal such a decision, leaving investors and other stakeholders watching both its market performance and any strategic actions it may take to support the share price and preserve its listing status.
More about Modular Medical
Modular Medical, Inc. is a medical device company focused on next-generation insulin delivery technology, including the first FDA-cleared patch pump specifically designed for adult “almost-pumpers” seeking a more user-friendly and affordable alternative. Using its patented technologies, the company aims to make high-quality insulin delivery simpler and more accessible, extending advanced glycemic control beyond experienced “superusers” to a broader diabetes population.
Average Trading Volume: 822,586
Technical Sentiment Signal: Sell
Current Market Cap: $29.6M
Learn more about MODD stock on TipRanks’ Stock Analysis page.